Genomics of Influenza A and Influenza B Viruses
Influenza viruses are members of the Orthomyxoviridae family whose genomes consist of 8 segments of single-stranded negative-sense RNA. Influenza A virus (IAV) and influenza B virus (IBV) are responsible for seasonal epidemics of respiratory illness among humans. While IBV circulates only among humans, IAV circulates among many mammalian and avian hosts. Global surveillance of these viruses is necessary for maintaining a well-matched annual influenza vaccine, as well as for detecting the emergence of new influenza strains that may cause a human pandemic. Hemagglutinin (HA) and neuraminidase (NA) are the two predominant viral glycoproteins found in the viral envelope, and are the primary targets of the host immune system and are key factors in the entry and exit of influenza particles from host cells. HA and NA are also used to classify influenza A viruses into subtypes (e.g., H3N2, H5N1).
Our collaborative influenza projects: 1) characterizing the temporal and spatial evolutionary dynamics of the IAV and IBV circulating globally in humans and wild birds, 2) identifying the IAV genotypes circulating in pigs at county fairs (swine-human interface) to determine if fairs produce novel reassortants or enable zoonosis/reverse zoonosis, 3) determining if specific internal gene segment constellations enhance viral fitness, 4) detecting epistatic interactions between gene segments, and 5) assessing the impact of inter-hemispheric migration of viruses/gene segments.
The accumulation of mutations at antigenic sites (antigenic drift) and the reassortment of segments with differing evolutionary histories (antigenic shift) allow influenza viruses to continually evade the host immune response. Annual human epidemics are currently caused by two IAV subtypes (A/H3N2, A/H1N1) and by two diverging IBV lineages (B/Yamagata, B/Victoria). IAVs circulating in avian and swine hosts are also important because of frequent interspecies transmission, which periodically causes human pandemics (e.g., pandemics of 1957, 1968, and 2009). Complete genome sequencing is required to identify fitness advantages conferred by genes and how antigenic drift in HA/NA drive mutations throughout the genome. Genomic sequence data will be generated from the diverse subtypes/strains (H1-H16, N1-N9) in avian reservoirs, which are a source of viruses with pandemic potential (e.g., H5N1). Swine are 'mixing vessels' for reassortment between avian and human viruses because they express sialic acid molecules that act as receptors for both avian and human viruses. Human, avian, and classical swine lineage viruses are co-circulating in North American swine populations, generating novel reassortants and leading to hundreds of zoonotic infections (e.g., H3N2v). The large number of co-circulating viruses in swine is the most genetically dynamic situation observed in North America over the last 90 years.
The Journal of general virology. 2017-04-01; 98.4: 577-584.
Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus
PLoS pathogens. 2017-03-22; 13.3: e1006292.
Journal of virology. 2017-02-01; 91.3:
Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model
PLoS pathogens. 2017-02-01; 13.2: e1006203.
Nucleic acids research. 2017-01-04; 45.D1: D466-D474.
Journal of virology. 2016-12-15; 90.24: 11247-11258.
Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification
mSphere. 2016-12-14; 1.6:
A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses
Journal of virology. 2016-12-01; 90.23: 10963-10971.
Introduction, Evolution, and Dissemination of Influenza A Viruses in Exhibition Swine in the United States during 2009 to 2013
Journal of virology. 2016-10-01; 90.19: 8454-63.
PLoS pathogens. 2016-05-01; 12.5: e1005620.
Journal of virology. 2016-02-15; 90.4: 1997-2007.
Molecular Evolution and Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States
Nature genetics. 2016-02-01; 48.2: 195-200.
The Journal of infectious diseases. 2016-01-15; 213.2: 173-82.
Microbiome. 2015-12-15; 3.74.
The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
Journal of virology. 2015-12-01; 89.23: 11935-44.
Nature. 2015-10-01; 526.7571: 122-5.
Journal of virology. 2015-09-01; 89.18: 9689-92.
The Journal of general virology. 2015-08-01; 96.8: 2050-60.
Influenza A virus evolution and spatio-temporal dynamics in Eurasian wild birds: a phylogenetic and phylogeographical study of whole-genome sequence data
Journal of virology. 2015-07-01; 89.13: 6860-73.
Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence
Emerging microbes & infections. 2015-06-17; 4.e35.
Long-term surveillance of H7 influenza viruses in American wild aquatic birds: are the H7N3 influenza viruses in wild birds the precursors of highly pathogenic strains in domestic poultry?
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2015-05-07; 20.18:
Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas
Journal of virology. 2015-05-01; 89.10: 5651-67.
Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression
Journal of virology. 2015-05-01; 89.10: 5427-40.
Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans
Journal of virology. 2015-05-01; 89.10: 5371-81.
Spread and persistence of influenza A viruses in waterfowl hosts in the North American Mississippi migratory flyway
Journal of virology. 2015-04-01; 89.8: 4706.
Nature communications. 2015-03-27; 6.6696.
Journal of virology. 2015-02-01; 89.4: 2442-7.
The Journal of general virology. 2015-02-01; 96.Pt 2: 269-76.
eLife. 2015-01-16; 4.e05055.
Evolutionary bioinformatics online. 2015-01-01; 11.43-8.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2014-12-01; 28.351-7.
Toward a method for tracking virus evolutionary trajectory applied to the pandemic H1N1 2009 influenza virus
Scientific data. 2014-10-14; 1.140033.
A comprehensive collection of systems biology data characterizing the host response to viral infection
PLoS pathogens. 2014-10-01; 10.10: e1004420.
Journal of virology. 2014-09-01; 88.17: 10110-9.
Introductions and evolution of human-origin seasonal influenza a viruses in multinational swine populations
Virology. 2014-08-01; 462-463.81-90.
Journal of virology. 2014-07-01; 88.14: 8153-65.
Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission
Journal of clinical microbiology. 2014-05-01; 52.5: 1330-7.
Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics
PloS one. 2014-01-01; 9.3: e92075.
North Atlantic migratory bird flyways provide routes for intercontinental movement of avian influenza viruses
Virology. 2013-12-01; 447.1-2: 45-51.
Metadata-driven comparative analysis tool for sequences (meta-CATS): an automated process for identifying significant sequence variations that correlate with virus attributes
Virology journal. 2013-06-06; 10.181.
PloS one. 2013-01-01; 8.5: e67616.
Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus
Molecular ecology. 2012-12-01; 21.24: 5905-7.
Nucleic acids research. 2012-07-01; 40.Web Server issue: W186-92.
Future virology. 2012-06-01; 7.6: 563-573.
Methods in molecular biology (Clifton, N.J.). 2012-01-01; 944.175-92.
PloS one. 2009-09-29; 4.9: e7264.
This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Award Numbers N01-AI30071 and U19AI110819.